Quartz·2 min read·medium

Alphabet's Isomorphic Labs raised $5 billion in Series C funding for AI drug design

Ella Rodrigo
✦AI Summary

Alphabet's AI-focused subsidiary, Isomorphic Labs, has secured $5 billion in Series C funding. The round was co-led by Greenoaks and Sequoia Capital to accelerate the development of AI-driven drug discovery programs.

Why it matters

This massive investment highlights the growing intersection of generative AI and biotechnology, signaling a major shift in how pharmaceutical research is conducted.

✦Dive DeeperCreate a free account to unlock

Greenoaks and Sequoia Capital co-led the round as the Alphabet…

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →

Also covering this story

2 other newsrooms covered this event. We read each version separately.

technologybusinessscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in